YD Bio (YDESW) Accounts Payables (2024 - 2026)
YD Bio's (YDESW) quarterly Accounts Payables came in at $371594.0 in Q2 2026, up 813.84% year-over-year from $40663.0 in Q2 2025, and down 10.09% quarter-over-quarter from $413290.0 in Q4 2025.
Analysis
YD Bio (YDESW) Accounts Payables (2024 - 2026) Analysis & Trends
YD Bio (YDESW) has reported Accounts Payables for 3 consecutive years, with $371594.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Accounts Payables rose 813.84% year-over-year to $371594.0 in Q2 2026; TTM through Jun 2026 was $371594.0, a 813.84% increase from a year earlier, with the FY2025 full-year figure at $413290.0, up 1438.34% from the prior year.
- Accounts Payables was $371594.0 for Q2 2026 at YD Bio, down from $413290.0 in the prior quarter.
- Over five years, Accounts Payables peaked at $413290.0 in Q4 2025 and troughed at $26866.0 in Q4 2024.
- A 3-year average of $213103.2 and a median of $206128.5 in 2025 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables surged 1438.34% in 2025 and surged 813.84% in 2026, its largest moves.
- Over 3 years, Accounts Payables stood at $26866.0 in 2024, then surged by 1438.34% to $413290.0 in 2025, then dropped by 10.09% to $371594.0 in 2026.
- The last three Accounts Payables figures came in at $371594.0 (Q2 2026), $413290.0 (Q4 2025), and $40663.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.51 Bn | 197.52 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 181.48 Bn | 178.30 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.45 Bn | 124.60 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.72 Bn | 49.59 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Roivant Sciences | 30.31 Bn | 30.31 Bn | 1.16 Mn | 25.08 Mn |
| 10 | YD Bio | 29.02 Mn | 26.36 Mn | - | 371,594.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 371,594.00 |
| Dec 31, 2025 | 413,290.00 |
| Jun 30, 2025 | 40,663.00 |
| Dec 31, 2024 | 26,866.00 |